196 related articles for article (PubMed ID: 19292900)
1. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.
Park HR; Ju EJ; Jo SK; Jung U; Kim SH; Yee ST
BMC Cancer; 2009 Mar; 9():85. PubMed ID: 19292900
[TBL] [Abstract][Full Text] [Related]
2. HemoHIM enhances the therapeutic efficacy of ionizing radiation treatment in tumor-bearing mice.
Park HR; Ju EJ; Jo SK; Jung U; Kim SH
J Med Food; 2010 Feb; 13(1):47-53. PubMed ID: 20136435
[TBL] [Abstract][Full Text] [Related]
3. Restoration of the immune functions in aged mice by supplementation with a new herbal composition, HemoHIM.
Park HR; Jo SK; Jung U; Yee ST
Phytother Res; 2008 Jan; 22(1):36-42. PubMed ID: 17705143
[TBL] [Abstract][Full Text] [Related]
4. HemoHIM ameliorates the persistent down-regulation of Th1-like immune responses in fractionated γ-irradiated mice by modulating the IL-12p70-STAT4 signaling pathway.
Park HR; Jo SK; Choi NH; Jung U
Radiat Res; 2012 May; 177(5):676-84. PubMed ID: 22439601
[TBL] [Abstract][Full Text] [Related]
5. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.
Lu Y; Wang Y; Miao L; Haynes M; Xiang G; Huang L
Cancer Lett; 2016 Aug; 379(1):32-8. PubMed ID: 27235608
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Anti-cancer Activity of MH-30 in a Murine Melanoma Model Treated With Cisplatin and its Alleviated Effects Against Cisplatin-induced Toxicity in Mice.
Park HR; Jo SK; Cho HH; Jung U
In Vivo; 2020; 34(4):1845-1856. PubMed ID: 32606154
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.
Molavi O; Ma Z; Hamdy S; Lai R; Lavasanifar A; Samuel J
Immunol Cell Biol; 2008; 86(6):506-14. PubMed ID: 18392040
[TBL] [Abstract][Full Text] [Related]
8. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H
Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389
[TBL] [Abstract][Full Text] [Related]
9. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
Kim H; Sin JI
Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
Kong LY; Gelbard A; Wei J; Reina-Ortiz C; Wang Y; Yang EC; Hailemichael Y; Fokt I; Jayakumar A; Qiao W; Fuller GN; Overwijk WW; Priebe W; Heimberger AB
Clin Cancer Res; 2010 May; 16(9):2550-61. PubMed ID: 20388845
[TBL] [Abstract][Full Text] [Related]
12. Antiinflammatory activity of an herbal preparation (HemoHIM) in rats.
Jo SK; Lee HJ; Kim SR; Kim JC; Bae CS; Jung U; Park HR; Jang JS; Kim SH
Phytother Res; 2007 Jul; 21(7):625-8. PubMed ID: 17486680
[TBL] [Abstract][Full Text] [Related]
13. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
Kim TS; Xu WS; Sun T; Cohen EP
Melanoma Res; 1995 Aug; 5(4):217-27. PubMed ID: 7496156
[TBL] [Abstract][Full Text] [Related]
14. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
15. Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression.
Kim SK; Kwon DA; Lee HS; Kim HK; Kim WK
Evid Based Complement Alternat Med; 2019; 2019():3494806. PubMed ID: 31015850
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and immunomodulatory activity of polysaccharides from the roots of Actinidia eriantha.
Xu HS; Wu YW; Xu SF; Sun HX; Chen FY; Yao L
J Ethnopharmacol; 2009 Sep; 125(2):310-7. PubMed ID: 19559777
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide from
Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of HemoHIM on immune and hematopoietic systems against γ-irradiation.
Park HR; Jo SK; Jung U; Yee ST; Kim SH
Phytother Res; 2014 Feb; 28(2):245-51. PubMed ID: 23595637
[TBL] [Abstract][Full Text] [Related]
20. The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.
Yang PM; Du JL; Wang GN; Chia JS; Hsu WB; Pu PC; Sun A; Chiang CP; Wang WB
Integr Cancer Ther; 2017 Sep; 16(3):319-328. PubMed ID: 27252074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
